CLINICAL_TRIALS
trial_result
· 2022-09-13
Clinical Trial Update: Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects [Phase 3]
Summary
Phase 3 trial evaluating macitentan in Fontan-palliated congenital heart disease completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Congenital Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-09-13